(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

EPIFINDER

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

EPIFINDER

ST13

US500000079405073

Classe

1, 5, 42, 44

Pedido

79405073

Registro

7998399

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

25

Atualização mais recente

29/05/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42, 44

Data de depósito

03/06/2024

Data de registro

28/10/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

28/10/2025

Última transação

29/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

SE

Examinador

MAHONEY, PAULA M

Unidade examinadora

N10

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Epigenica AB

Representantes

Joseph R. Dages Gray Ice Higdon, PLLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Genetic and epigenetic identity tests comprised of reagents for non-medical purposes; reagents for research purposes; reagents for medical research; reagents for scientific purposes; chemical diagnostic reagents for industrial purposes; reagents for chemical analyses of biological samples for scientific research and diagnostic purposesother than for medical or veterinary purposes; chemical reagents for use in genetic and epigentic research; reagents for use in immunoserology for research purposes; diagnostic reagents for scientific use; reagents for use in environmental analysis for scientific use; biochemical reagents used for non-medical purposes; biochemical reagentsnamely DNA polymerasesused for non-medical purposes; chemical diagnostic reagents for industrial use; diagnostic reagents for scientific useother than for medical laboratory use; chemical reagents for non-medical purposes; diagnostic reagents for scientific or research use; immunoassay reagents for scientific useother than for medical use; in-vivo diagnostic reagents for scientific use; chemical reagents for scientific useother than for medical or veterinary purposes; reagents for scientific or medical research use; diagnostic reagentsexcept for medical or veterinary use; reagents for laboratory purposesother than for medical or veterinary purposes; biomolecule labelling kits comprising reagents for use in scientific research; nucleic acid amplification reagentsother than for medical use; diagnostic reagents and preparationsexcept for medical or veterinary use; reagents for use in diagnostic testsother than for medical or veterinary purposes; reagents for analytical purposes for scientific useother than for medical or veterinary purposes; chemical reagents for molecular biology for scientific useother than for medical or veterinary use; chemical reagents for laboratory use for scientific useother than for medical or veterinary use; chemical reagents for use in science for scientific useother than for medical or veterinary use; reagents for microbiological analysis for scientific useother than for medical or veterinary purposes; chemical reagents for use with immunoassay analyzers for scientific useother than for medical or veterinary use; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria; diagnostic reagentsother than for medical use for sale in kit form; chemical reagents for use in biotechnology for scientific useother than for medical or veterinary use; reagents for use with analyzers for scientific useother than for medical or veterinary purposes; chemical reagents for use in diagnostic tests for scientific purposesother than for medical or veterinary use; reagents for use in analytical tests for scientific useother than for medical or veterinary purposes; chemical reagents for use in diagnosis for scientific useother than for medical or veterinary use; chemical reagents for use in analytical tests for scientific useother than for medical or veterinary use; nucleic acids; nucleic acid reagents for use in forensic analysisother than for medical purposes; nucleic acid sequencing programs for scientific useother than for medical use; chromatographic materialsilica gel and ion-exchange resins for the treatment of nucleic acids for scientific laboratory use; monoclonal antibodies other than for medical or veterinary usefor scientific purposes; tagged fluorescein- and biotin-labelled monoclonal antibodies for laboratory use; tagged fluorescein- and biotin-labelled monoclonal antibodies for scientific use; monoclonal antibodies for scientific use; monoclonal antibodies for industrial use; immunological antibodiesother than for medical use; monoclonal antibodies for diagnostic useother than medical; proteins for use in science; proteins for binding antibodiesother than for medical use; enzymesother than for medical use for labelling proteins; enzymesother than for medical use for measuring proteins; proteins for detecting antibodiesother than for medical use; reagents for protein foldingprotein refolding buffersother than for medical or veterinary purposes; proteins for use in recombinant dna technology for scientific useother than for medical use; enzymesother than for medical use for detecting protein fractions; enzymesother than for medical use for measuring protein fractions; enzymesother than for medical use for labelling protein fractions; enzymes for industrial purposes; enzymes for use as biochemical catalysts; enzymes for scientific useother than for medical or veterinary use; enzymes for scientific purposes; chemicalsbuffer solutions used in analytical chemistry; buffer solutions for scientific purposes; buffer solutions for use in analytical chemistry; substances for use in genetic and epigenetic probe assay kits for scientific usenot for medical use; biochemical preparations for scientific purposes; biochemical precursors for scientific purposes; biochemical preparations other than for medical use; biochemical substancesDNA polymerases and nucleasesother than for medical use; chemical substances for use in bioluminescent processes; biological preparations for use in industry and science; catalystsrestriction enzymes and ligasesfor use in non-biological processes; biological substancesnucleic acid and recombinant proteinsother than for medical or veterinary use; biochemicalsepigenetic assay buffers and nucleosome standardsfor use as indicatorsother than for medical use; reagents for use in biological processing for scientific useother than for medical or veterinary purposes; chemicals for use in the pharmaceutical industryreagents for drug formulation and quality control assays; chemical preparations for use in the manufacture of pharmaceuticalsTris-HCl buffersphosphate-buffered saline (PBS)nucleic acid primers

Classe 5

Nucleic acid sequences for medical and veterinary purposes; reagents for use in diagnostic tests for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical use; diagnostic preparations and materialsdiagnostic reagents containing primers and probesfor medical use; diagnostic reagents for medical use; diagnostic reagents for medical use in in vitro diagnosis; diagnostic substances for medical use; radio-isotope markers for therapeutic or diagnostic use; diagnostic chemical reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes used by medical laboratories; chemical preparations for use in DNA analysis for medical use; DNA synthesis inhibitors for medical use; chemical test reagents for medical purposes

Classe 42

Medical and scientific researchconducting clinical trials for others; design and development of diagnostic apparatus for epigenetic biomarker detection and analysis; DNA screening for scientific research purposes; DNA analysis services for scientific research purposes; research in the field of DNA repair technology; research in the field of DNA chip technology; clinical research in the field of oncologyneurologydiabetesreproductive healthlifestyle diseases; medical research laboratory research services; medical research; genetic and epigenetic research in plantsanimalshumans; laboratory testing of biological materials; scientific laboratory services; analytical laboratory services in the field of epigenetic biomarker detection; laboratory services for analytical testing in the field of molecular diagnostics; medical research laboratory services; laboratory research in the field of gene expression; services of a chemical and/or biological laboratorychemical laboratoriesbiological research laboratory services; scientific research in the field of genetics and epigenetics; genetic and epigenetic mapping for scientific purposes; DNA sequencing technology research; development of testing methods for epigenetic biomarker analysis; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; preparation of biological samples for testing and analysis in research laboratories; testingauthentication and quality control for laboratory reagents and consumables

Classe 44

Medical services for the diagnosis of conditions of the human body; medical analysis for the diagnosis and treatment of persons; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; blood serum analysis of RNA or DNAbeing medical analysis services for cancer diagnosis and prognosis purposes provided by medical laboratories; medical analysis services for cancer diagnosis and prognosis; DNA screening for medical purposes; medical and health services relating to DNAgenetics and epigeneticsgenetic and epigenetic testinggenetic and epigenetic testing for cancer risk for medical purposes; genetic and epigenetic testing for medical purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

25 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

28/05/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/05/2026

FIMP

FINAL DISPOSITION PROCESSED

09/05/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

12/03/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

25/02/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

25/02/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

28/01/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

28/10/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

28/10/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/09/2025

PUBO

PUBLISHED FOR OPPOSITION

09/09/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/09/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/08/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/07/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/07/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

25/07/2025

RFNT

REFUSAL PROCESSED BY IB

22/02/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/02/2025

RFRR

REFUSAL PROCESSED BY MPU

06/02/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/01/2025

CNRT

NON-FINAL ACTION WRITTEN

31/12/2024

DOCK

ASSIGNED TO EXAMINER

14/12/2024

MAFR

APPLICATION FILING RECEIPT MAILED

01/10/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/10/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

26/09/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace EPIFINDER ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.